603363 Fujian Aonong Biological Technology Group Incorporation
- 3.62
- -0.10-2.69%
Fujian Aonong Biological Technology Group Incorporation News
Research Report Nuggets | Guoxin Securities: Aonong Biotech is expected to lose 38-500 million yuan in Q2. Future fattening production capacity is expected to increase steadily and maintain its “buy” rating
Aonong Biotech (603363) 2023 semi-annual report performance forecast review: 2023Q2 loss is expected to be 38-500 million yuan, and state-owned asset war investment stocks are expected to help the company's long-term development
Aonong Biotech (603363): Results for the third quarter were slightly lower, and there is still room for cost reduction
Aonong Biotech (603363): Financial situation improved, operation improved steadily
Aonong biology (603363): steady expansion of farmed feed is expected to benefit pig prices.
Aonong biology (603363): pig production capacity releases feed against the trend
Aonong biology (603363) company information update report: pig production continues high growth feed business volume and price pressure
Aonong Biology (603363): steady growth of Feed Business and breeding Business is expected to improve
Aonong Biology (603363): the company's loss narrowed in the second quarter and is expected to turn a loss into profit for the whole year.
Comments on Aonong Biological (603363) 2021 Annual report and 2022 Quarterly report: capacity release and operational improvement
Aonong Biology (603363): continuous growth of live pigs and steady development of feed business
Comments on the Annual report and Quarterly report of Aonong Biology (603363): the rapid growth of feed business of live pigs
Aonong Biology (603363): aquaculture business under pressure, low fattening ratio, low short-term financial pressure
Aonong creature (603363): new stars in breeding are ready to go.
Aonong Biology (603363): the main feed industry steadily develops the fresh force of pig breeding.
Aonong creature (603363) depth report: Longteng braved the wind and waves
Analysis on the value of Aonong's debt-to-debt Investment: highly flexible Agricultural and Animal Husbandry Enterprises with double main Industry Development suggest to pay active attention to it
Aonong biology (603363) 2021 performance forecast quick review: pig breeding rookie fattening capacity steadily increased
Aonong Biology (603363): revenue scale leaps up and aquaculture business drags down current performance
Comments on the three-quarter report of Aonong Biology (603363): the rapid expansion of pig production capacity and the outstanding performance of feed business
Analysis
Price Target
No Data
